Using Epidemiology and Genomics to Understand Osteosarcoma Etiology
暂无分享,去创建一个
[1] L. S. Schmidt,et al. Birth characteristics and Wilms tumors in children in the Nordic countries: A register‐based case–control study , 2011, International journal of cancer.
[2] D. Malkin. Li-fraumeni syndrome. , 2001, Genes & cancer.
[3] Pu Li,et al. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma , 2010, Molecular carcinogenesis.
[4] R. Hayes,et al. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. , 2010, Carcinogenesis.
[5] S. Doublier,et al. Fluoride effects: the two faces of janus. , 2010, Current medicinal chemistry.
[6] E. Pignotti,et al. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] L. Larizza,et al. Rothmund-Thomson syndrome , 2010, Orphanet journal of rare diseases.
[8] J. Behren,et al. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype , 2009, British Journal of Cancer.
[9] Magali Olivier,et al. TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.
[10] H. Pan,et al. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls , 2010, Molecular Biology Reports.
[11] Yong Zhang,et al. Association between TGFBR1*6A and osteosarcoma: A Chinese case-control study , 2010, BMC Cancer.
[12] A. Vaporciyan,et al. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients , 2010, Journal of Cancer Research and Clinical Oncology.
[13] T. Lightfoot,et al. Birth weight, sex and childhood cancer: A report from the United Kingdom Childhood Cancer Study. , 2009, Cancer epidemiology.
[14] R. Layfield,et al. Recent advances in understanding the molecular basis of Paget disease of bone , 2009, Journal of Clinical Pathology.
[15] Lisa Mirabello,et al. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons , 2009, International journal of cancer.
[16] P. Picci,et al. Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival , 2009, Clinical Cancer Research.
[17] M. Tucker,et al. Cause-specific mortality in long-term survivors of retinoblastoma. , 2009, Journal of the National Cancer Institute.
[18] L. Mirabello,et al. Osteosarcoma incidence and survival rates from 1973 to 2004 , 2009, Cancer.
[19] W. Gong,et al. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies. , 2009, Carcinogenesis.
[20] Paul D. P. Pharoah,et al. p53 polymorphisms: cancer implications , 2009, Nature Reviews Cancer.
[21] C. Khanna,et al. Bridging the gap between experimental animals and humans in osteosarcoma. , 2009, Cancer treatment and research.
[22] G. Ottaviani,et al. The etiology of osteosarcoma. , 2009, Cancer treatment and research.
[23] Preetha Rajaraman,et al. Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations , 2009, Pediatric Radiology.
[24] M. Pollak,et al. Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.
[25] C. Errani,et al. Osteosarcoma in patients older than 65 years. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] V. Bohr,et al. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis , 2008, Human Genetics.
[27] R. Hayes,et al. Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. , 2008, Human molecular genetics.
[28] Thomas Harder,et al. Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. , 2008, American journal of epidemiology.
[29] Julian Peto,et al. Association of Genetic Variants at 8q24 with Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.
[30] J. Ross,et al. Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.
[31] R. Sankila,et al. Osteosarcoma in Finland from 1971 through 1990 A nationwide study of epidemiology and outcome , 2008, Acta orthopaedica.
[32] F. Sim,et al. Malignant bone tumors. , 2001, Instructional course lectures.
[33] P. Choong,et al. A review of clinical and molecular prognostic factors in osteosarcoma , 2008, Journal of Cancer Research and Clinical Oncology.
[34] Q. Wei,et al. Exploratory Analysis of Fas Gene Polymorphisms in Pediatric Osteosarcoma Patients , 2007, Journal of pediatric hematology/oncology.
[35] E. Steliarova-Foucher,et al. Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] W. Wallace,et al. Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004. , 2007, The Journal of bone and joint surgery. British volume.
[37] M. Wallander,et al. The impact of birth weight on prostate cancer incidence and mortality in a population‐based study of men born in 1913 and followed up from 50 to 85 years of age , 2007, The Prostate.
[38] P. Scheidt,et al. Cohort profile: the International Childhood Cancer Cohort Consortium (I4C). , 2007, International journal of epidemiology.
[39] S. Chanock,et al. Analysis of Genes Critical for Growth Regulation Identifies Insulin-like Growth Factor 2 Receptor Variations with Possible Functional Significance as Risk Factors for Osteosarcoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[40] S. Chanock,et al. Germ‐line genetic variation of TP53 in osteosarcoma , 2007, Pediatric blood & cancer.
[41] A. Stewart,et al. Osteosarcoma, Chondrosarcoma, and Ewing's Sarcoma: National Cancer Data Base Report , 2007, Clinical orthopaedics and related research.
[42] M. Forman,et al. Birthweight by gestational age and childhood cancer , 2007, Cancer Causes & Control.
[43] A. Whittemore,et al. Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.
[44] M. Tucker,et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. , 2007, Journal of the National Cancer Institute.
[45] M. Gadelha,et al. Osteosarcoma and acromegaly: A case report and review of the litereture , 2006, Journal of endocrinological investigation.
[46] M. Hansen,et al. Osteosarcoma in Paget's Disease of Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] R. Hoover,et al. Perinatal factors, growth and development, and osteosarcoma risk , 2006, British Journal of Cancer.
[48] K. Michels,et al. Role of birthweight in the etiology of breast cancer , 2006, International journal of cancer.
[49] E. Steliarova-Foucher,et al. Cancer incidence and survival in European adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.
[50] E. Steliarova-Foucher,et al. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.
[51] C. Douglass,et al. Caution Needed in Fluoride and Osteosarcoma Study , 2006, Cancer Causes & Control.
[52] D. Altshuler,et al. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. , 2006, Journal of the National Cancer Institute.
[53] A. Craft,et al. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994 , 2005, British Journal of Cancer.
[54] David Wypij,et al. Age-specific Fluoride Exposure in Drinking Water and Osteosarcoma (United States) , 2006, Cancer Causes & Control.
[55] C. Bonaïti‐pellié,et al. Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome , 2005, Journal of Medical Genetics.
[56] Pinchas Cohen,et al. The role of the insulin-like growth factor system in prenatal growth. , 2005, Molecular genetics and metabolism.
[57] K. McCaul,et al. Primary malignant bone tumours in Western Australia, 1972–1996 , 2005, Pathology.
[58] F. Berrino,et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] S. Bull,et al. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] E. Steliarova-Foucher,et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study , 2004, The Lancet.
[61] A. Levine,et al. A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.
[62] A. Ogose,et al. Osteosarcomas after the Age of 50: A Clinicopathologic Study of 64 Cases—an Experience in Northern Japan , 2004, Annals of Surgical Oncology.
[63] G. Bacci,et al. Height as a risk factor in osteosarcoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] M. Pearce,et al. Stature of young people with malignant bone tumors , 2004, Pediatric blood & cancer.
[65] L. Robison,et al. Big babies and infant leukemia: a role for insulin-like growth factor-1? , 1996, Cancer Causes & Control.
[66] J. German,et al. Bloom's syndrome , 1972, Humangenetik.
[67] M. Melbye,et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. , 2003, American journal of epidemiology.
[68] A. Patiño-García,et al. Analysis of Polymorphisms of the Vitamin D Receptor, Estrogen Receptor, and Collagen I&agr;1 Genes and Their Relationship With Height in Children With Bone Cancer , 2003, Journal of pediatric hematology/oncology.
[69] Jennifer R. Harris,et al. Heritability of adult body height: a comparative study of twin cohorts in eight countries. , 2003, Twin research : the official journal of the International Society for Twin Studies.
[70] A. Sandberg,et al. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. , 2003, Cancer genetics and cytogenetics.
[71] J. Squire,et al. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. , 2003, Cancer genetics and cytogenetics.
[72] E. Ron,et al. CANCER RISKS FROM MEDICAL RADIATION , 2003, Health physics.
[73] J. W. van der Eijken,et al. Osteosarcoma over the age of forty. , 2003, European journal of cancer.
[74] M. Coleman,et al. Childhood cancer survival in Europe and the United States , 2002, Cancer.
[75] M. Stovall,et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] Kenneth Chu,et al. Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC , 2002, Science.
[77] Jacques P. Brown,et al. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.
[78] B. Carsi,et al. Primary Osteosarcoma in Adults Older Than 40 Years , 2002, Clinical orthopaedics and related research.
[79] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] J. Oshima,et al. Werner Syndrome , 2020, Constitutional Oncogenetics.
[81] D. Lev,et al. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. , 2001, American journal of medical genetics.
[82] L. D. Da Costa,et al. Diamond-Blackfan Anemia , 2019, Clinical Disorders and Experimental Models of Erythropoietic Failure.
[83] J. Lipton,et al. Osteogenic Sarcoma Associated With Diamond–Blackfan Anemia: A Report From the Diamond–Blackfan Anemia Registry , 2001, Journal of pediatric hematology/oncology.
[84] Robert W. Miller,et al. Atypical Osteosarcomas in Werner Syndrome (Adult Progeria) , 2000, Japanese journal of cancer research : Gann.
[85] A. Patiño-García,et al. Analysis of the human tumour necrosis factor-alpha (TNFα) gene promoter polymorphisms in children with bone cancer , 2000, Journal of medical genetics.
[86] N. Jaffe,et al. Osteosarcoma in Preadolescent Patients , 2000, Clinical orthopaedics and related research.
[87] N. Mohandas,et al. Diamond-Blackfan anemia , 2000, Current opinion in hematology.
[88] J. Buckley,et al. Epidemiology of osteosarcoma and Ewing's sarcoma in childhood , 1998, Cancer.
[89] R. Grimer,et al. Longitudinal Growth Following Treatment for Osteosarcoma , 1998, Sarcoma.
[90] S. Hwang,et al. Growth and development and other risk factors for osteosarcoma in children and young adults. , 1997, International journal of epidemiology.
[91] E. Kramárová,et al. The international classification of childhood cancer , 1996, International journal of cancer.
[92] D. Lucas. Dahlin’s Bone Tumors: General Aspects and Data on 11,087 Cases , 1996 .
[93] D. Parkin,et al. Geographic and ethnic variations in the incidence of childhood cancer. , 1996, British medical bulletin.
[94] Y. Ishikawa,et al. Excess of rare cancers in Werner syndrome (adult progeria). , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[95] K. Unni,et al. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases , 1996 .
[96] H. Tideman. Abstract from international literatureBone cancers: H. D. Dorfman, B. Czerniak Cancer 1995: 75: 203–10 , 1995 .
[97] L. Robison,et al. Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type , 1995, Cancer.
[98] H. Tsukuma,et al. Survival Rates of Childhood Cancer Patients in Osaka, Japan, 1975–1984 , 1995, Japanese journal of cancer research : Gann.
[99] B. Czerniak,et al. Bone cancers , 1995, Cancer.
[100] D. Leroith,et al. Insulin-like Growth Factors and Cancer , 1995, Annals of Internal Medicine.
[101] N. Breslow,et al. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess. , 1994, Cancer research.
[102] S. Hirschfeld,et al. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. , 1994, Cancer research.
[103] B. Novakovič. U.S. childhood cancer survival, 1973-1987. , 1994, Medical and pediatric oncology.
[104] D. Parkin,et al. International variations in the incidence of childhood bone tumours , 1993, International journal of cancer.
[105] F. Sim,et al. Postradiation sarcoma of bone. , 1972, Orthopedics.
[106] J. Healey,et al. The effect of chemotherapy on growth in the skeletally immature individual. , 1991, Clinical orthopaedics and related research.
[107] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[108] C. Polychronakos,et al. Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma. , 1990, Journal of the National Cancer Institute.
[109] J. Mann,et al. The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): case control study of children with bone and soft tissue sarcomas. , 1988, British Journal of Cancer.
[110] D. Parkin,et al. The international incidence of childhood cancer , 1988, IARC scientific publications.
[111] S. Preston‐Martin,et al. A case-control study of osteosarcoma in young persons. , 1987, American journal of epidemiology.
[112] C. Pui,et al. Height at diagnosis of malignancies. , 1987, Archives of disease in childhood.
[113] A. Huvos. Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years , 1986, Cancer.
[114] A. Polednak. Primary bone cancer incidence in black and white residents of New York state , 1985, Cancer.
[115] N. Samaan,et al. Hormonal evaluation in patients with osteosarcoma , 1985, Journal of surgical oncology.
[116] W. Taylor,et al. Trends and variability in survival among patients with osteosarcoma: a 7-year update. , 1985, Mayo Clinic proceedings.
[117] D. Dahlin. Prognostic factors in osteosarcoma. , 1980, International journal of radiation oncology, biology, physics.
[118] L. Broström,et al. Longitudinal growth and dental development in osteosarcoma patients. , 1980, Acta orthopaedica Scandinavica.
[119] A. Drash,et al. Metabolic and endocrine alterations in osteosarcoma patients , 1978, Cancer.
[120] P. Scranton,et al. Prognostic factors in osteosarcoma: A review of 20 years' experience at the university of pittsburgh health center hospitals , 1975 .
[121] P. Scranton,et al. Prognostic factors in osteosarcoma: A review of 20 years' experience at the university of pittsburgh health center hospitals , 1975, Cancer.
[122] R. Lorentzon,et al. The incidence of malignant primary bone tumours in relation to age, sex and site. A study of osteogenic sarcoma, chondrosarcoma and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. , 1974, The Journal of bone and joint surgery. British volume.
[123] J. Fraumeni,et al. Epidemiology of bone cancer in children. , 1970, Journal of the National Cancer Institute.
[124] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[125] J. Fraumeni. Stature and malignant tumors of bone in childhood and adolescence , 1967, Cancer.
[126] M. Lomicek,et al. [Malignant bone tumors]. , 1957, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca.
[127] C. H. Price. Osteogenic Sarconma; An Analysis of the Age and Sex Incidence , 1955, British Journal of Cancer.
[128] G. David Roodman,et al. Paget disease of bone , 2012, Radiopaedia.org.